Anticoagulants Market In The US to grow at a CAGR of 6.67% during the period 2016-2020.

“The Report Anticoagulants Market in the US 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”




About the Anti-Coagulant Drugs Market


Anticoagulants have been used for over 80 years to treat clotting disorders. It is used as a first line of defense for disorders such as deep vein thrombosis (DVT), pulmonary embolism, AF, and acute coronary syndrome. With the advent of time, traditional therapies are replaced by novel oral anticoagulants, which have better safety and efficacy profiles.


The 1990s saw rapid development in the field of direct thrombin inhibitors. Though these drugs, such as hirudin, have been in use from the early 19th century, they were accepted with the development of genetic engineering technology. The recombinant forms, such as desirudin, are also available in the market. During the same period, the focus shifted toward the development of factor Xa inhibitors, and by early 2000s, the first indirect factor Xa inhibitor, fondaparinux, was released into the market. These drugs were administered by parenteral route.


Technavios analysts forecast the Anti-Coagulants Market in the US to grow at a CAGR of 6.67% during the period 2016-2020.


Covered in this report


The report covers the present scenario and the growth prospects of the anti-coagulants market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generics drugs used to treat coagulation disorders. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market.


Download Detail Report With Complete TOC at:


Technavio’s report, Anti-Coagulants Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors

Johnson & Johnson

Bristol-Myers Squibb

Boehringer Ingelheim


Daiichi Sankyo


Other prominent vendors

Armatheon Inc.





Cosmo Pharmaceuticals SA

CSL Behring, Eisai, GSK

Marathon Pharmaceuticals LLC

Ockham Biotech


Portola Pharmaceuticals

Sagent Pharmaceuticals Inc.

The Medicines Company

Urigen Pharmaceuticals Inc.

Valeant Pharmaceuticals


Market driver

Growing prevalence of coagulation disorders

For a full, detailed list, view our report


Market challenge

Side-effects associated with drugs

For a full, detailed list, view our report


Market trend

Expected exploitation of new therapeutic use

For a full, detailed list, view our report


Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?


Browse all latest Press Releases of Market Research Reports



About us is the most comprehensive collection of market research reports.

MarketResearchReports.Biz services are specially designed to save time and money for our clients.

We are a one stop solution for all your research needs, our main offerings are syndicated research

reports, custom research, subscription access and consulting services. We serve all sizes and types

of companies spanning across various industries.






Mr. Nachiket

90 Sate Street,

Suite 700  Albany,

NY 12207 USA

Tel: +1-518-621-2074

Canada Toll Free: 866-997-4948